These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8434955)
1. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid]. Ohno R Gan To Kagaku Ryoho; 1993 Feb; 20(2):189-93. PubMed ID: 8434955 [TBL] [Abstract][Full Text] [Related]
2. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid]. Ohno R; Naoe T; Fukutani H Gan To Kagaku Ryoho; 1993 Jun; 20(8):1016-21. PubMed ID: 8390226 [TBL] [Abstract][Full Text] [Related]
3. Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukaemia Study Group of the Ministry of Health and Welfare. Ohno R; Yoshida H; Fukutani H; Naoe T; Ohshima T; Kyo T; Endoh N; Fujimoto T; Kobayashi T; Hiraoka A Leukemia; 1993 Nov; 7(11):1722-7. PubMed ID: 8231241 [TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239 [TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan. Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028 [TBL] [Abstract][Full Text] [Related]
6. Management of acute promyelocytic leukemia relapse in the ATRA era. Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255 [TBL] [Abstract][Full Text] [Related]
7. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients. Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888 [TBL] [Abstract][Full Text] [Related]
8. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule. Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658 [TBL] [Abstract][Full Text] [Related]
10. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. de Botton S; Coiteux V; Chevret S; Rayon C; Vilmer E; Sanz M; de La Serna J; Philippe N; Baruchel A; Leverger G; Robert A; San Miguel J; Conde E; Sotto JJ; Bordessoule D; Fegueux N; Fey M; Parry A; Chomienne C; Degos L; Fenaux P J Clin Oncol; 2004 Apr; 22(8):1404-12. PubMed ID: 15084614 [TBL] [Abstract][Full Text] [Related]
11. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Al Bahar S; Pandita R; Bavishi K; Kreze O Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411 [TBL] [Abstract][Full Text] [Related]
12. [Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia]. Yamada O; Hatake K; Tanimoto M; Ishiyama T; Ohno R; Shirakawa S; Horiuchi A; Tomonaga M; Ohta K Gan To Kagaku Ryoho; 1994 Sep; 21(12):1981-9. PubMed ID: 8085849 [TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies. Tallman MS Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584 [TBL] [Abstract][Full Text] [Related]
14. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience]. Sun GL Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):125-9. PubMed ID: 8223122 [TBL] [Abstract][Full Text] [Related]
16. Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukaemia. Colović MD; Janković GM; Elezović I; Vidović A; Bila JS; Novak A; Babić D Med Oncol; 1997 Jun; 14(2):65-72. PubMed ID: 9330265 [TBL] [Abstract][Full Text] [Related]
17. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL). Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of acute promyelocytic leukemia by all trans retinoic acid]. Castaigne S; Degos L C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565 [TBL] [Abstract][Full Text] [Related]
19. [Induction and maintenance therapy in all-trans retinoic acid with relapsed acute promyelocytic leukemia]. Takitani K; Kawamura N; Yamaguchi H; Morinobu W; Yoshida N; Watanabe K; Miyake M; Tatsumi K; Mino M Rinsho Ketsueki; 1995 Feb; 36(2):147-52. PubMed ID: 7715086 [TBL] [Abstract][Full Text] [Related]
20. [Scrotum exfoliative dermatitis with ulcers associated with treatment of acute promyelocytic leukemia with all-trans retinoic acid]. Tajima K; Sagae M; Yahagi A; Akiba J; Suzuki K; Hayashi T; Satoh S Rinsho Ketsueki; 1998 Jan; 39(1):48-52. PubMed ID: 9492553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]